“Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s636, https://doi.org/10.25251/57ey8s02.